Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
McKinsey
Mallinckrodt
Boehringer Ingelheim
Dow

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Belcher Pharms Llc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BELCHER PHARMS LLC, and what generic alternatives to BELCHER PHARMS LLC drugs are available?

BELCHER PHARMS LLC has eight approved drugs.

There are three US patents protecting BELCHER PHARMS LLC drugs.

Summary for Belcher Pharms Llc
US Patents:3
Tradenames:7
Ingredients:7
NDAs:8

Drugs and US Patents for Belcher Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Belcher Pharms Llc TACROLIMUS tacrolimus CAPSULE;ORAL 206651-002 Nov 30, 2017 AB RX No No   See Pricing   See Pricing
Belcher Pharms Llc EPINEPHRINE epinephrine SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS 205029-001 Jul 29, 2014 RX Yes Yes 10,004,700   See Pricing Y   See Pricing
Belcher Pharms Llc SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 205727-001 Feb 23, 2016 AA RX No No   See Pricing   See Pricing
Belcher Pharms Llc EPINEPHRINE epinephrine SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS 205029-001 Jul 29, 2014 RX Yes Yes 10,039,728   See Pricing   See Pricing
Belcher Pharms Llc TACROLIMUS tacrolimus CAPSULE;ORAL 206651-003 Nov 30, 2017 AB RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Harvard Business School
Moodys
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.